Further studies will be required to assess whether longitudinal blood measurement of PTX3 levels may represent a novel biomarker more sensitive than psychosine to predict onset after newborn screening and to follow disease progression in transplanted and/or late-onset GLD patients. Here, PTX3 is linked to Krabbe disease.